Tarperprumig Placebo, Tarperprumig
ALXN1820-ANCA-201
Phase 2 small_molecule active
Quick answer
Tarperprumig Placebo, Tarperprumig for Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is a Phase 2 program (small_molecule) at Alexion Europe SAS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alexion Europe SAS
- Indication
- Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active